ELDN vs NSC · $209.6M cap vs P/E 18, rev $6.46B
Eledon Pharmaceuticals Inc (ELDN) versus Norfolk Southern Corporation (NSC) — a side-by-side from cached financials, not a winner call.
Eledon Pharmaceuticals Inc (ELDN) is a biotechnology company listed on US.
Norfolk Southern Corporation (NSC) is a railroads company listed on US.
ELDN does not have a complete income-statement cache yet.
Latest reported NSC revenue for 2026-06-30 was $6.46B. Net income was $1.28B. NSC currently screens at market cap $60.10B and trailing P/E 18.2.
ELDN currently screens at market cap $209.6M. NSC currently screens at market cap $60.10B and trailing P/E 18.2.
Not investment advice. Open the ELDN and NSC stock pages for the full models.
Not investment advice.